MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Symbol
MRVI on Nasdaq
Shares outstanding
144,919,287
Price per share
$3.25
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
130,723,266
Total reported value
$375,086,051
% of total 13F portfolios
0%
Share change
+1,133,760
Value change
+$4,399,524
Number of holders
158
Price from insider filings
$3.25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
12 West Capital Management LP 8.2% $24,341,804 11,591,335 12 West Capital Management LP 31 Dec 2024
FELDMAN STUART 6.2% +28% $25,662,162 +$5,955,594 8,941,520 +30% Stuart Feldman 30 Sep 2025
BlackRock, Inc. 5.9% $24,626,187 8,580,553 BlackRock, Inc. 30 Sep 2025
VANGUARD GROUP INC 4.9% -23% $20,450,179 -$6,471,991 7,125,498 -24% The Vanguard Group 30 Sep 2025

As of 30 Sep 2025, 158 institutional investors reported holding 130,723,266 shares of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI). This represents 90% of the company’s total 144,919,287 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) together control 78% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
GTCR LLC 14% 20,150,005 0% 6.4% $57,830,514
12 West Capital Management LP 8.6% 12,521,335 0% 3.7% $35,936,231
BlackRock, Inc. 6.3% 9,103,866 -6.1% 0% $26,128,094
BRAIDWELL LP 5.8% 8,353,287 0% 0.71% $23,973,934
VANGUARD GROUP INC 4.9% 7,125,498 -24% 0% $20,450,179
T. Rowe Price Investment Management, Inc. 4.2% 6,158,235 +133% 0.01% $17,675,000
MACKENZIE FINANCIAL CORP 4.2% 6,069,301 0% 0.02% $17,418,894
RENAISSANCE TECHNOLOGIES LLC 3% 4,318,089 +3.2% 0.02% $12,392,915
MIRABELLA FINANCIAL SERVICES LLP 2.6% 3,750,000 0% 0.94% $10,762,500
Monaco Asset Management SAM 2.5% 3,656,337 +315% 3.9% $10,493,687
MORGAN STANLEY 2% 2,883,767 +0.23% 0% $8,276,412
GEODE CAPITAL MANAGEMENT, LLC 1.9% 2,813,658 -5.7% 0% $8,076,843
Philosophy Capital Management LLC 1.8% 2,593,268 0% 0.86% $7,442,679
Point72 (DIFC) Ltd 1.8% 2,588,887 -30% 0.52% $7,430,106
Tejara Capital Ltd 1.7% 2,453,441 +26% 3.9% $7,041,376
UBS Group AG 1.7% 2,399,212 -26% 0% $6,885,738
STATE STREET CORP 1.6% 2,387,030 +0.24% 0% $6,850,776
DEUTSCHE BANK AG\ 1.3% 1,888,046 +0.73% 0% $5,418,692
ROYCE & ASSOCIATES LP 1.2% 1,761,764 +38% 0.05% $5,056,263
CenterBook Partners LP 1.2% 1,691,873 +3.5% 0.24% $4,855,676
TWO SIGMA ADVISERS, LP 1.1% 1,651,400 -26% 0.01% $4,739,518
AMERIPRISE FINANCIAL INC 1.1% 1,606,878 -1% 0% $4,611,740
GOLDMAN SACHS GROUP INC 1.1% 1,572,155 +15% 0% $4,512,084
LAZARD ASSET MANAGEMENT LLC 1.1% 1,540,226 +6.2% 0.01% $4,420,449
SYSTEMATIC FINANCIAL MANAGEMENT LP 1.1% 1,522,791 -8.9% 0.11% $4,370,412

Institutional Holders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 427,663 $1,390,235 -$236,681 $3.25 3
2025 Q3 130,723,266 $375,086,051 +$4,399,524 $2.87 158
2025 Q2 129,598,496 $312,340,233 +$3,793,907 $2.41 147
2025 Q1 128,634,753 $283,834,530 -$79,892,021 $2.21 183
2024 Q4 139,560,056 $760,601,118 -$45,938,934 $5.45 179
2024 Q3 143,975,137 $1,196,310,633 -$27,771,239 $8.31 216
2024 Q2 147,328,491 $1,054,857,572 +$79,315,696 $7.16 199
2024 Q1 135,289,396 $1,172,685,389 +$22,484,101 $8.67 206
2023 Q4 400,347 $2,627,101 +$1,129,987 $6.55 4
2023 Q3 134,407,355 $1,343,121,204 +$77,000,409 $10.00 198
2023 Q2 126,100,195 $1,570,233,670 -$35,432,765 $12.43 213
2023 Q1 127,948,506 $1,791,144,332 +$17,005,999 $14.01 208
2022 Q4 126,651,492 $1,812,260,448 -$135,727,572 $14.31 199
2022 Q3 129,053,643 $3,294,745,925 +$11,698,467 $25.53 181
2022 Q2 130,960,717 $3,719,622,813 +$80,612,677 $28.41 198
2022 Q1 127,743,533 $4,506,539,221 -$19,955,440 $35.27 224
2021 Q4 128,000,156 $5,361,992,646 -$43,575,589 $41.90 216
2021 Q3 127,248,380 $6,245,026,780 +$684,250,429 $49.08 218
2021 Q2 114,339,745 $4,771,559,656 +$729,957,540 $41.73 190
2021 Q1 98,286,366 $3,502,883,156 +$129,457,061 $35.64 138
2020 Q4 97,444,087 $2,733,175,243 +$1,943,807,357 $28.05 112